Axcella Health Inc. Common Stock
AXLA
AXLA was delisted on the 22nd of November, 2023.
31 hedge funds and large institutions have $50.4M invested in Axcella Health Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 3 closing their positions.
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 32 → 31 (-1)
14% less capital invested
Capital invested by funds: $58.6M → $50.4M (-$8.21M)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
+$615K |
| 2 |
State Street
Boston,
Massachusetts
|
+$240K |
| 3 |
BlackRock
New York
|
+$178K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$64.8K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$45.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIC
Chilton Investment Company
Stamford,
Connecticut
|
-$202K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$184K |
| 3 |
PCM
Pinz Capital Management
New York
|
-$137K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$59K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$41.1K |
AXLA Hedge Fund Activity: Q1 2020 in Review
31 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q1 2020, worth a combined $50.4M — down 14% from $58.6M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of AXLA and 2 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 14 added.
The largest buyer was Artal Group, adding an estimated $615K. The largest seller was Chilton Investment Company, cutting an estimated $202K.
- 31 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q1 2020, down from 32 in Q4 2019.
- Funds reported $50.4M of Axcella Health Inc. Common Stock stock for Q1 2020, down 14% quarter-over-quarter.
- 2 funds opened new Axcella Health Inc. Common Stock positions in Q1 2020 and 3 closed out, a net change of -1 holder.
- The largest Axcella Health Inc. Common Stock buyer in Q1 2020 was Artal Group, an estimated $615K added.
- The largest Axcella Health Inc. Common Stock seller in Q1 2020 was Chilton Investment Company, an estimated $202K sold.
Based on aggregated 13F filings for Q1 2020.